CRI Impact Grant
CRI Impact Grant supports researchers conducting clinically relevant chordoma research that bridges laboratory and clinical discovery to translate immunological findings into cancer immunotherapies.
Browse similar grants
Funder: Cancer Research Institute
Due Dates: December 1, 2026 (Letter of Intent)
Funding Amounts: $300,000 total funding
Summary: Supports clinically relevant research translating immunological discoveries into immunotherapies for chordoma.
Description
The Cancer Research Institute (CRI) Impact Grant supports clinically relevant research that bridges laboratory discovery and clinical discovery to advance immunotherapies for chordoma. Its purpose is to accelerate the translation of discoveries in immunology into cancer therapies, with chordoma as the specific focus of the supported work.
The grant sits within CRI’s broader commitment to advancing cancer immunotherapy. Through competitive grants, fellowships, and awards, the institute supports scientific discovery and the development of life-saving immunotherapies. The Impact Grant brings that mission to research connecting immunological discoveries with questions relevant to clinical care for chordoma.
